A review of irritable bowel syndrome and an update on therapeutic approaches

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.7, 2008-05, pp. : 1129-1143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Irritable bowel syndrome: an update on therapeutic modalities

By Farhadi Ashkan Bruninga Keith Fields Jeremy Keshavarzian Ali

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1211-1222

Informa Healthcare

Access to resources Recommend Favorite

Irritable Bowel Syndrome: Recent and Novel Therapeutic Approaches

By Andresen Viola Camilleri Michael

Drugs, Vol. 66, Iss. 8, 2006-01 ,pp. : 1073-1088

Adis International

Access to resources Recommend Favorite

Review of tegaserod in the treatment of irritable bowel syndrome

By Patel Sonal Berrada Driss Lembo Anthony

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2369-2379

Informa Healthcare

Access to resources Recommend Favorite

Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?

By Gloro Romain Ducrotte Philippe Reimund Jean-Marie

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1079-1095

Informa Healthcare

Access to resources Recommend Favorite

CRF1 Receptors as a Therapeutic Target for Irritable Bowel Syndrome

Current Pharmaceutical Design, Vol. 12, Iss. 31, 2006-01 ,pp. : 4071-4088

Bentham Science Publishers

Access to resources Recommend Favorite